ArticleCancer medicine2024

Analysis of the clinical efficacy and safety of anti-PD-1 immune checkpoint inhibitors in locally advanced nasopharyngeal cancer.

Shuling Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.